药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Stepronin
Rapacuronium
The therapeutic efficacy of Glycerin can be decreased when used in combination with Rapacuronium.
Stepronin
Isopropamide
The therapeutic efficacy of Glycerin can be decreased when used in combination with Isopropamide.
Stepronin
Solifenacin
The therapeutic efficacy of Glycerin can be decreased when used in combination with Solifenacin.
Nitroxoline
Sulfate ion
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Sulfate ion.
Nitroxoline
Sodium cation
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Sodium cation.
Nitroxoline
Dehydrocholic acid
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Dehydrocholic acid.
Nitroxoline
Frangula purshiana bark
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Frangula purshiana bark.
Nitroxoline
Alloin
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Alloin.
Nitroxoline
Konjac mannan
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Konjac mannan.
Nitroxoline
Emodin
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Emodin.
Nitroxoline
Oxyphenisatin acetate
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Oxyphenisatin acetate.
Nitroxoline
Sodium phosphate, monobasic, unspecified form
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Sodium phosphate, monobasic, unspecified form.
Nitroxoline
Potassium sulfate
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Potassium sulfate.
Nitroxoline
Sodium ascorbate
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Sodium ascorbate.
Nitroxoline
Magnesium glycinate
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Magnesium glycinate.
Nitroxoline
Sodium fluorophosphate
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Sodium fluorophosphate.
Nitroxoline
Plantago ovata seed
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Plantago ovata seed.
Nitroxoline
Zinc
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Zinc.
Nitroxoline
Deacetylbisacodyl
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Deacetylbisacodyl.
Nitroxoline
Plecanatide
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic is combined with Plecanatide.